Top-News

Impax Laboratories News

Keine aktuellen Kursdaten verfügbar
WKN: 938461
ISIN: US45256B1017
Typ: Aktie

Impax Laboratories News

07.05.18 - PR Newswire
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax
ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax PR Newswire
07.05.18 - PR Newswire
Amneal and Impax Complete Business Combination
Amneal and Impax Complete Business Combination ‒ Creates Diversified Pharmaceutical Company with 5th Largest Generics Business in the United States ‒ ‒ Combined First ...
02.05.18 - PR Newswire
Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600
Apergy Set to Join S&P MidCap 400; 3D Systems to Join S&P SmallCap 600 PR Newswire
27.04.18 - PR Newswire
Amneal And Impax Receive FTC Clearance For Business Combination
Amneal And Impax Receive FTC Clearance For Business Combination PR Newswire
27.04.18 - PR Newswire
ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax
ANI Pharmaceuticals Signs Definitive Agreements to Acquire Generic Products and Assets from Amneal/Impax PR Newswire
06.04.18 - PR Newswire
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)
Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) PR Newswire
27.03.18 - PR Newswire
Impax Shareholders Approve Proposed Business Combination with Amneal
Impax Shareholders Approve Proposed Business Combination with Amneal PR Newswire
14.03.18 - PR Newswire
Amneal Gains Approval for Erythromycin Tablets USP
Amneal Gains Approval for Erythromycin Tablets USP PR Newswire
07.03.18 - PR Newswire
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference
Amneal Pharmaceuticals and Impax Laboratories to Present at the Barclays Global Healthcare Conference PR Newswire
01.03.18 - PR Newswire
Amneal Launches Generic for Tamiflu® Oral Suspension
Amneal Launches Generic for Tamiflu® Oral Suspension PR Newswire
01.03.18 - PR Newswire
Impax Reports Fourth Quarter and Full Year 2017 Results
Impax Reports Fourth Quarter and Full Year 2017 Results - Q4 2017 Total Revenues of $183 Million; GAAP Net Loss Per Share of $4.18; Non-GAAP Adjusted Income Per Share of ...
21.02.18 - PR Newswire
Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR®
Amneal Introduces Memantine Hydrochloride Extended-​Release Capsules, Generic for Namenda XR® PR Newswire
20.02.18 - PR Newswire
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-Release Tablets
Impax Announces the Launch of an Authorized Generic Version of Solodyn® (Minocycline HCl) Extended-​Release Tablets PR Newswire
06.02.18 - PR Newswire
Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations
Andrew S. Boyer Joins Amneal Pharmaceuticals as Executive Vice President, Commercial Operations PR Newswire
05.02.18 - PR Newswire
Amneal Launches Methylphenidate Hydrochloride Extended-Release Tablets, USP (CII) AB-Rated Generic for Concerta®
Amneal Launches Methylphenidate Hydrochloride Extended-​Release Tablets, USP (CII) AB-Rated Generic for Concerta® PR Newswire
01.02.18 - PR Newswire
Amneal Introduces Isotretinoin Capsules, USP
Amneal Introduces Isotretinoin Capsules, USP PR Newswire
30.01.18 - PR Newswire
CorePharma, LLC Acquired by Investor Group
CorePharma, LLC Acquired by Investor Group PR Newswire
24.01.18 - PR Newswire
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream
Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream PR Newswire
16.01.18 - PR Newswire
Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018
Impax to Report Fourth Quarter and Full Year 2017 Results on March 1, 2018 PR Newswire
03.01.18 - PR Newswire
Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference
Amneal Pharmaceuticals and Impax Laboratories to Present at the 36th Annual J.P. Morgan Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »